It has been suggested that lysosomes and the lysosomal proteases cathepsin D and B act as proapoptotic mediators of apoptosis, in addition to mitochondrial release of cytochrome c and the activation of the caspase family of proteases. We found that cathepsin D was implicated in the onset of apoptosis in fibroblasts exposed to oxidative stress generated by redox cycling of naphthazarin (NZ) (5,8-dihydroxy-1,4-naphthoquinon). At the start of NZ treatment, the intracellular reduced glutathione concentration was diminished and cathepsins D, B, and L were all translocated from lysosomes to the cytosol before any biochemical or morphological signs of apoptosis were detected. Increase in cathepsin D activity and in the level of p53 protein, a transcription factor for cathepsin D, was observed before activation of caspase-3. Moreover, pretreatment with the cathepsin D inhibitor pepstatin A or the caspase-3 inhibitor Ac-DEVD-CHO prevented apoptosis, although the increase of cathepsin D activity was still detected when caspase-3 was inhibited. Cathepsin B activity decreased following oxidative stress, and inhibition of the protease did not affect the apoptotic process. We suggest that translocation of lysosomal proteases is an early event in NZ-induced apoptosis and that the release and increased activity of cathepsin D allow this protease to exert an apoptosis-mediating effect upstream of the caspase cascade.
cathepsin D and a few lysosomal cysteine proteases, for instance cathepsins B and L. Deiss and co-workers (6) found that cathepsin D anti-sense RNA protected HeLa cells from IFN-γ-and Fas-induced cell death. It has also been demonstrated that p53, which accumulates rapidly after various types of stress, has two binding sites located at the cathepsin D promoter gene, and that cathepsin D participates in p53-dependent apoptosis (7) . Apoptosis induced in hepatocytes by bile salts also appears to be regulated by cathepsin D, possibly through a cathepsin-D-mediated increase in cathepsin B activity, which might lead to caspase activation (8) (9) (10) .
Addressing the question of whether subcellular translocation of cathepsin D occurs during apoptosis, we have previously shown that lysosomes release cathepsin D to the cytosol during mild oxidative stress, and this release appears to be an early event that precedes the release of cytochrome c from mitochondria (11, 12) . Other studies conducted in our laboratory have indicated that the lysosomal destabilization plays an important role in apoptosis initiated by a variety of stimuli, such as oxidative stress, lysosomal photo-oxidation, growth-factor withdrawal, or Fas-activation (13) (14) (15) (16) .
The overall objective of the present study was to examine lysosomal destabilization and the relationship between caspase activation and the lysosomal proteases cathepsins D and B in regard to their effects on apoptosis. To achieve this objective, foreskin fibroblasts were exposed to oxidative stress induced by treatment with naphthazarin (NZ).
MATERIALS AND METHODS

Cells and culture conditions
Human foreskin fibroblasts of the AG-1518 line (passages 12-20; Coriell Institute Camden, NJ) were cultured in Eagle's minimum essential medium (EMEM) supplemented with 2 mM glutamine, 50 IU/ml penicillin-G, 50 µg/ml streptomycin, and 10% fetal bovine serum (all from GIBCO, Paisley, U.K.). The cells were incubated in humidified air with 5% CO 2 at 37°C and subcultured once a week. Before experiments, the cells were trypsinized and seeded in 35-mm dishes (Costar, Cambridge, MA) at a density of 10,000 cells/cm2. For light microscopy, round glass coverslips were placed in Petri dishes before cell plating. NZ (5,8-dihydroxy-1,4-naphtoquinon, Aldrich Chemie, Steinheim, Germany) was dissolved in ethanol (2 mM stock solution) and added to cultures in prewarmed serum-free medium, and the cells were incubated at 37°C. The toxicity of NZ is highly dependent on cell density, and we used NZ concentrations of 0.5-0.8 µM to obtain an equitoxic experimental system. Pepstatin A (Sigma, St. Louis, MO), which inhibits the aspartic proteases cathepsin D, pepsin, and renin, was dissolved in water-free DMSO (25 mM stock solution) and added to complete EMEM at 37°C (100 µM). Treatment with pepstatin A was started 24 h before adding NZ and was also added during exposure to NZ. Experiments with pepstatin A concentrations ranging from 100 nM to 100 µM did not inhibit the activity of 50 ng/ml active recombinant caspase-3 (Becton-Dickinson, Mountain View, CA). The cathepsin B inhibitor CA-074 Me (0.1 µM; Peptide Institute, Inc, Osaka, Japan) was added to cultures 1 h before NZ, and the same was done with Ac-DEVD-CHO (50 µM; BectonDickinson), an inhibitor of caspase-3-like proteases.
Immunofluorescence detection of cathepsins D, B, and L
Fibroblasts grown on coverslips were fixed in 4% paraformaldehyde for 20 min at 4°C, and then processed for immunocytochemistry as previously described (13) . Briefly, the cells were incubated with a polyclonal rabbit anti-human cathepsin D antibody (dilution 1:25; Zymed, Stockholm, Sweden) or a polyclonal rabbit anti-human cathepsin B or L antibody (dilution 1:50; Athens Research and Technology, Athens, GA), followed by a goat anti-rabbit IgG-Texas Red conjugate (1:200; Vector Laboratories, Burlingame, CA). Finally the cells were rinsed in PBS and distilled water and mounted in Vectashield. Cells were examined and photographed in a Nikon photomicroscope by using green excitation light and a red barrier filter. Cells incubated without the primary antibodies, used as negative controls, showed no staining.
Detection of apoptosis
Cells were fixed in 4% formaldehyde, stained with 5% Giemsa solution (Merck, Darmstadt, Germany), and examined in a light microscope to evaluate cell shrinkage and nuclear condensation. Caspase-3-like activity was determined by using the fluorescence substrate Ac-DEVD-AMC (Becton-Dickinson) according to the recommendations of the manufacturer. This substrate is cleaved by activated caspase-3-like proteases, and we analyzed the fluorescence of liberated AMC (7-amino-4-methyl-coumarin) at λex 380 nm and λem 435 nm in a spectrofluorometer. Caspase-3-like activity was expressed as picomoles of AMC released per milligram of protein; AMC concentration was calculated by using a standard curve.
Determination of the activity of cathepsins B and D
Cathepsin B activity was determined as described by Barrett (17) . In short, culture medium was withdrawn, and the cells were washed in PBS and lysed in a 340 mM sodium acetate buffer (pH 5.0) containing 0.1% triton X-100, 60 mM acetic acid, 4 mM EDTA, and 8 mM dithiothreitol. The cell lysate was incubated for 15 min at 30°C with the cathepsin-B-specific substrate z-ArgArg-AMC (20 µM; Sigma). Adding a buffer consisting of 100 mM sodium monochloric acetate, 30 mM sodium acetate, and 70 mM acetic acid stopped the reaction. The fluorescence of liberated AMC was analyzed at λex 380 nm and λem 435 nm in a spectrofluorometer. Cathepsin B activity was expressed as picomoles of AMC released per milligram of protein, and AMC concentration was calculated by using a standard curve.
Cathepsin D activity was determined as described by Barrett (18) by using hemoglobin as a substrate. In short, culture medium was withdrawn, and the cells were washed in PBS and lysed by three cycles of freezing and thawing. Sodium phosphate buffer (2 mM, pH 6.5) was added, and the cell lysate was collected in test tubes on ice. The lysate was mixed with 250 µl of 4% hemoglobin (Sigma) and 250 µl of sodium formate buffer (1 M, pH 3.5) and then incubated at 45°C for 60 min. The reaction was terminated by adding 5 ml of 3% trichloric acid, and the precipitate was filtered. The amount of peptides released was estimated by the method described by Lowry et al (19) with some modifications (18) . Cathepsin D activity was expressed as absorbance units (a.u.) per milligram of protein, and we found that activity corresponding to 0.1 a.u./mg protein was inhibited completely by 0.75 nM pepstatin A.
Western blotting
Cells were lysed in 63 mM Tris-HCl (pH 6.8), 10% glycerol, 2% SDS, 5% 2-mercaptoethanol, and 0.05% bromphenol blue. The protein concentration was determined, and 40 µg aliquots of the cell lysate were fractionated by 15% SDS-PAGE. The proteins were subsequently transferred to a nitrocellulose membrane, which was incubated in a blocking solution (5% skimmed milk and 0.1% Tween-20 in TBS; i.e., 50 mM Tris buffer supplemented with 0.15 M NaCl) for 90 min at room temperature and then washed in TBS. Thereafter, the membranes were exposed for 16 h at 4°C to a mouse anti-human p53 monoclonal antibody (Sigma) diluted 1:1000 in 0.1% skimmed milk and 0.05% Tween-20 in TBS. We washed and incubated the membranes for 1 h at room temperature with horseradish peroxidase (HRP)-conjugated goat anti-mouse secondary antibodies (diluted 1:1500; DAKO, Carpinteria, CA), and we visualized the bands by using enhanced chemiluminescence (Amersham Pharmacia Biotech, Little Chalfont Buckinghamshire, U.K.).
Production of reactive oxygen species
We measured production of reactive oxygen species (ROS) as the total luminol-enhanced chemiluminescence during NZ exposure. In each well of a 96-well plate, 0.8 × 106 unexposed or exposed fibroblasts were mixed with 300 µl (10 µg/ml) luminol (5-amino-2,3-dihydro-1,4-phthalazinedione free acid, Sigma) and 30 µl (4 U/ml) peroxidase (Boehringer-Mannheim) in PBS. We recorded chemiluminescence with a VICTOR 1420 multiple counter (Wallac, Turku, Finland).
Reduced glutathione analysis
Samples for reduced glutathione (GSH) analysis were prepared by collecting the cells in 0.5 M HClO4 supplemented with 1 mM EDTA. We centrifuged the samples at 300 x g for 10 min and analyzed the supernatants by HPLC and electrochemical detection as previously described (20) . GSH concentrations were calculated from standard curves, and protein was determined as described by Lowry et al.
Statistical analysis
We repeated all experiments at least four times. Statistical significance was calculated by using the Mann-Whitney U-test. Values are given as arithmetic means ± SD; P-values = 0.05 (*) were considered significant.
RESULTS
NZ-induced apoptosis increases the activity of caspase-3 and cathepsin D but decreases the activity of cathepsin B
The caspase-3-like activity increased after 12 h of treatment with NZ. By comparison, the activity of cathepsin D was augmented after 4 h of NZ treatment and peaked at 16 h (Fig. 1A, B) .
Moreover, increased levels of p53, a transcription factor for cathepsin D, were detected after exposure to NZ for 4 h (Fig. 1D) . The total protein level did not change in response to p53 induction and was estimated to 8.2 ± 3.5, 8.0 ± 2.1, and 7.1 ± 1.4 µg protein/10,000 cells after 0, 12, and 20 h, respectively. We also found that NZ caused a rapid decrease in the activity of the lysosomal cysteine protease cathepsin B (Fig. 1C) .
Inhibition of cathepsin D or caspase-3 prevents naphthazarin-induced apoptosis
Geimsa staining of cultures of NZ-treated fibroblasts revealed signs of apoptosis, such as decreased cell size and pycnotic nuclei ( Fig. 2A, B) , which agrees with changes in NZ-treated fibroblasts that have previously been detected by transmission electron microscopy (12) . Pretreatment with the cathepsin D inhibitor pepstatin A prevented apoptosis in NZ-treated cells (Fig. 2C) , and these cells subsequently continued to proliferate and could be subcultured. Pretreatment with the caspase-3-like inhibitor Ac-DEVD-CHO prevented apoptosis in fibroblasts exposed to NZ for up to 24 h (Fig. 2E) , whereas no such inhibition was detected after pretreatment with CA-074 Me to inhibit cathepsin B (Fig. 2D ). In addition, pretreatment of fibroblasts with pepstatin A or Ac-DEVD-CHO-but not with CA-074 Me-inhibited activation of caspase-3 (Fig. 3) . To investigate the link between cathepsin D and caspase-3, we measured cathepsin D activity while inhibiting caspase-3 with Ac-DEVD-CHO. We found no significant change in cathepsin D activity between fibroblasts exposed to NZ only (191 ± 40 % of control) and fibroblasts exposed to NZ in combination with Ac-DEVD-AMC (169 ± 20 % of control). Furthermore, studies showed that pepstatin A did not inhibit active recombinant caspase-3, 109 ± 9% of control.
Subcellular localization of cathepsins D, B, and L during exposure to NZ
The role of cathepsin D in the apoptotic process has been documented (6, 7), although the subcellular localization of the protease during such cell death was not established in these studies. Using immunocytochemistry, we detected granular staining of cathepsin D in control cells (Fig. 4A) . After 30 min of NZ treatment, fluorescence staining was more diffuse, indicating that cathepsin D had started to translocate from lysosomes to the cytosol; after 1 h, most of the cathepsin D was detected in the cytosol (Fig. 4B) . These results are consistent with a previous study in our laboratory, in which immuno-transmission electron microscopy revealed the presence of cathepsin D in lysosomes in control cells and translocation of the enzyme to the cytosol after NZ exposure (21) . NZ-exposed cells tend to shrink, and the fluorescence appears to be nuclear. Because we have never detected cathepsin D in nuclei by using immuno-transmission electron microscopy, we believe that the fluorescence is not truly nuclear but arises from cytosolic cathepsin D. Figures 4C-D show that treatment with pepstatin A or Ac-DEVD-CHO did not prevent cathepsin D translocation to the cytosol. The cathepsins B and L were similarly relocated from the lysosomes during the first hour of NZ exposure (Fig. 4E-H) .
Intracellular redox state during apoptosis
It has been suggested that ROS and intracellular redox state act as signal mediators during apoptosis, because antioxidant treatment prevents apoptosis in several systems. Studies have shown that intracellular metabolism of NZ generates oxygen free radicals, and quinone cytotoxicity can be inhibited by treatment with antioxidants (11, 22) . To elucidate the generation of ROS production in our experimental system, we measured luminol-enhanced chemiluminescence (Fig. 5A) . Luminescence was enhanced 1.5-fold after 15 min of NZ treatment, and a decrease in the intracellular concentration of GSH was detected at the same time. Thereafter, the chemiluminescence declined, and the GSH level was restored. Cells pretreated with pepstatin A showed the same reaction pattern, which indicates that pepstatin A does not act as a free radical scavenger (Fig. 5B) .
DISCUSSION
Cathepsin D is a major cellular aspartic protease that has numerous functions within the lysosomal compartment, the best known of which is proteolysis of endocytosed and autophagocytosed proteins at low pH. Earlier it was generally assumed that lysosomes were stable during apoptosis because they appear to be ultrastructurally intact in apoptotic cells. Lysosomal rupture has instead been considered to take place in necrosis. We found, however, that during mild oxidative stress lysosomes participate in apoptosis through early translocation of the lysosomal proteases to the cytosol. Exposure to NZ causes generation of free radicals and increased oxidative stress, detected as luminol enhanced chemiluminescence and a decrease in GSH after 15 min of exposure to NZ. The lysosomal membranes are exposed to increased amounts of reactive oxygen species that might initiate lipidperoxidation reactions in intracellular membranes and lead to release of lysosomal content. One of the present hypotheses that describes lysosomal membrane damage originates from intracellular production of hydrogen peroxide that might diffuse into the lysosome. Inside the lysosomal apparatus, low-molecularweight iron, the acidic milieu, and the occurrence of the reducing amino acid cysteine, would promote iron-reduction and Fenton-like chemistry destabilizing the lysosomal membranes and, thereby, causing lysosomal leakage (23) . It has also been found that atractyloside, which is commonly used to induce the mitochondrial permeability transition and release of cytochrome c from mitochondria, could induce release of cathepsin B from isolated lysosomes (10) . This observation raises the possibility that similar mechanisms of pore opening might exist in mitochondria and lysosomes.
Free radicals were generated during treatment with NZ, but the overall redox state of the cell decreased very slowly. We have previously observed an initial and rapid fluctuation in both ATP and mitochondrial membrane potential (∆Ψm) in fibroblasts exposed to NZ (12) . In that study, the cathepsin D inhibitor pepstatin A blocked the initial depletion of ATP and release of cytochrome c. The cytosolic targets for cathepsin D have not been ascertained, although it is possible that this enzyme has an effect exerted directly on mitochondrial function.
Cathepsin D showed augmented activity soon after it was released and that was accompanied by increased level of p53 protein, which is a cathepsin D transcription factor (7). The mechanism responsible for increase in CD activity might be an effect of increased synthesis regulated by p53. Both the release of cathepsin D and a significant increase in cathepsin D activity was detected before caspase-3 was activated.
Results reported in the literature indicate that an increase in the cytosolic concentration of cathepsin D may have a specific impact on apoptosis. First, unlike the cysteine lysosomal proteases, the aspartic proteases have no counteracting endogenous cytosolic inhibitors that limit extralysosomal proteolysis (24) . Second, assays in vitro have shown that cathepsin D is stable in the pH range 1-9 (25) and displays significant activity above pH 6.5 (26, 27) . Consequently, cathepsin D may mediate apoptosis by cleaving cytosolic substrates, although our preliminary data indicate that caspase-3 is not activated directly by cathepsin D (Kågedal et al, unpublished  data) . In a recent study of cathepsins B, H, K, L, S, and X, no direct activation of caspase zymogenes was found. Instead, an indirect mode of caspase activation by lysosomal proteases was found through Bid cleavage. Bid was cleaved in the presence of lysosomal extracts and incubation of mitochondria with Bid that had been cleaved by lysosomal extract resulted in cytochrome c release (28) .
Several other lysosomal enzymes are probably translocated to the cytosol together with cathepsins D, B, and L due to oxidative stress, and these enzymes may also be involved in implementing apoptosis. In our system, cathepsin B activity decreased rapidly during NZinduced apoptosis, and a similar phenomenon has been observed in PC12 cells during apoptosis invoked by serum deprivation (29, 30) . These data suggest that the increased activity of cathepsin D does not occur to compensate for the unspecific loss of this enzyme during translocation from lysosomes but is rather a way for the cells to regulate the apoptotic process.
Several investigations have indicated that lysosomes and lysosomal enzymes are involved in regulation of cell death. Sensibar and co-workers (31) studied castrated rats and found that an increase in cathepsin D activity and enlargement of the lysosomal compartment led to the death of prostate cells. Monney et al (32) have demonstrated that alkalization of acidic vesicles attenuates tumor necrosis factor α(TNF-α)-induced apoptosis. TNF-α-induced apoptosis has also been shown to cause cathepsin B release from lysosomes (33) . In addition, it has been suggested that generation of ceramide by acidic sphingomyelinases present in acidic vesicles mediates apoptosis elicited by stress and TNF-α. In that context, other investigators have shown that sphingosine and ceramide bind to and activate cathepsin D (34) , which provides a link between lysosomal proteolytic enzymes and TNF-α-induced apoptosis. Also, two recent papers have provided evidence of the involvement of lysosomal enzymes in apoptotic degradation of nuclear DNA (35, 36) . The numerous independent observations mentioned above suggest that cathepsin D can participate in the processes included in apoptosis. Nevertheless, not all models of apoptosis implicate the role of cathepsins, because experiments with cathepsin inhibitors have demonstrated caspase dependent apoptosis (37).
In our study, examination of morphology and caspase-3-like activity showed that apoptosis was prevented by the cathepsin D inhibitor pepstatin A and the caspase-3-like inhibitor Ac-DEVD-CHO. If caspase-3 and cathepsin D are activated in parallel pathways, inhibition of cathepsin D will not affect caspase activation. However, such an effect did occur in our experiments, which strongly suggests a connection between cathepsin D and caspases in NZ-induced apoptosis and also that cathepsin D apparently is involved upstream of the caspase cascade. Because apoptosis could be prevented for only 24 h by using a caspase-3 inhibitor, we speculate that the release of cytochrome c might cause cell death in this case. An earlier report from our group showed that inhibition of cathepsin D prevented cytochrome c release, which might explain the cellular survival using an cathepsin D inhibitor. These conclusions are further strengthened by our observation that Ac-DEVD-CHO did not inhibit the increase in cathepsin D activity. It is also possible that, besides its role in apoptosis induction, cathepsin D further exacerbates the apoptosis process in the later stages due to an amplification loop.
Taken together our data strongly implicate the lysosomal protease cathepsin D in apoptosis induction and potentiation, and further support the emerging picture of cathepsin D as an important mediator of programmed cell death. cleavage of Ac-DEVD-AMC. B) Cathepsin D activity determined by using hemoglobin as a substrate; 100% activity is defined as 0.074 U/mg protein, where 1 U will produce an absorbance-increase of 1.0 at A 750 in 30 min at pH 3.3 at 45°C, measured as TCA soluble products by using acid denatured hemoglobin as substrate. Notice that the cathepsin D activity was significantly higher after 8 h. A significant difference in caspase-3-like activation was found after 12 h, * P calculated by the Mann-Whitney U test. C) Cathepsin B activity analyzed by using z-Arg-Arg-AMC as a substrate. One U will liberate 1 nmole AMC/min at pH 6.0 at 40°C. D) Immunoblot analysis of p53 during NZ treatment. Values are means ± SD, n = 4. Symbols: Time course of GSH concentration in fibroblasts that were or were not pretreated with pepstatin A (100 µM) and then exposed to NZ (B).
